skip to Main Content

Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation

Newsfeed image, light gray text on dark gray background
Irreversible electroporation (IRE) is a novel treatment for locally advanced pancreatic cancer (LAPC), but the predictive factors, based on cytokines and immunocytes of survival, are still lacking.

This study aimed to establish a risk model based on cytokines and immunocytes for LAPC patients undergoing IRE treatment. Read more . . . 

Back To Top